Podcasts about Reimbursement

Book a call: https://remnantfinance.com/calendar ! Out Print the Fed with 1% per week: https://remnantfinance.com/optionsEmail us at info@remnantfinance.com or visit https://remnantfinance.com for more informationFOLLOW REMNANT FINANCEYoutube: @RemnantFinance (https://www.youtube.com/@RemnantFinance )Facebook: @remnantfinance (https://www.facebook.com/profile.php?id=61560694316588 )Twitter: @remnantfinance (https://x.com/remnantfinance )TikTok: @RemnantFinanceDon't forget to hit LIKE and SUBSCRIBE_____________________________Most people don't think about long-term care until they're forced to and by then, it's often too late to get coverage. The statistics are stark: there's a 68% chance any American will need long-term care at some point, and for couples, that number jumps to nearly 90%. Yet most families never have the conversation until a health event forces their hand.In this episode, Hans sits down with Travis McBride — fellow Navy helicopter pilot turned insurance strategist — to break down everything you need to know about long-term care planning.Chapters: 00:00 – Opening segment 02:35 – Travis's background04:50 – What the brokerage does and who they serve 13:40 – Long-term care 101: statistics and why it matters 16:45 – The three ways to fund long-term care 17:20 – Traditional LTCI: how it works and the use-it-or-lose-it problem 18:50 – How carriers mispriced policies in the 90s and 2000s 24:10 – The premium increase trap: stuck and uninsurable 25:20 – Are the premiums guaranteed? 35:05 – Life insurance with an LTC rider38:50 – The six activities of daily living explained 43:05 – Hybrid/asset-based policies: repositioning vs. spending 45:15 – How leverage works inside a hybrid policy 52:30 – Reimbursement vs. cash indemnity55:45 – Who should be thinking about this and when 1:01:25 – What Medicare actually covers and what it doesn't 1:07:15 – The Washington State payroll tax 1:16:25 – How to connect with Travis Key Takeaways:Ask one question before signing anything: are the premiums guaranteed? Traditional long-term care policies were mispriced in the 90s and early 2000s, and carriers have been sending premium increase notices ever since. Know how your benefits are paid before you need them. Reimbursement policies require receipts and ongoing claims filings every month. Cash indemnity policies cut you a check once you qualify and let you use it however you want.Self-insuring isn't insurance — it's just liquidation. Having enough assets to cover a long-term care event sounds like a plan until you run the math. A nursing facility in Southern California runs $6,000 to $15,000 a month, and that's today's cost. Hybrid policies reposition assets — they don't just spend them. Unlike traditional LTCI where premiums vanish if you never file a claim, hybrid linked-benefit policies give you liquidity, control, and a residual death benefit. The best time to have this conversation is before someone needs to. The sweet spot for getting coverage is 45 to 60, when you're still healthy enough to qualify and premiums haven't become prohibitive. By 65, you're entering the game late. 

In this episode, Patrick Velliky, Chief External Affairs Officer at HaloMD, breaks down the latest trends in health care policy, payer consolidation, and the No Surprises Act. He explains how providers can navigate reimbursement challenges, reduce administrative burdens, and focus on delivering care while staying independent.This episode is sponsored by HaloMD.

In this episode of Medsider Radio, we sat down with Rick Bente, co-founder and CEO of Indomo.Indomo's flagship device, ClearPen, is an investigational at-home corticosteroid injection designed to treat inflammatory acne.Rick has over 20 years of experience as an engineer and operator across medtech and pharma, with leadership roles at Medtronic, Insulet, and YourBio, focused on drug delivery and combination products. He is an inventor on more than 50 patents and has generated over $150 million in investments.In this conversation, Rick discusses how Indomo translated an in-office dermatology procedure into at-home care, why usability had to be engineered rather than trained, how the company decided when to exit stealth mode, and how proof-based milestones shaped its fundraising.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Rick Bente.

Renaud delivers this emergency bonus podcast to provide a timely update on the news of February 21, 2026, after a landmark 6–3 U.S. Supreme Court decision that struck down many of the tariffs imposed during President Trump's second term. The episode explains which measures were affected, the immediate legal and financial fallout, and provides expert analysis of the political and strategic responses. For manufacturers, importers, and supply-chain managers, Renaud also outlines the operational implications.   P.S. Later on 21/2/26, Trump wrote on Truth Social: "I, as President of the United States of America, will be, effective immediately, raising the 10% Worldwide Tariff on Countries, many of which have been ‘ripping' the U.S. off for decades, without retribution (until I came along!), to the fully allowed, and legally tested, 15% level.” - so this confirms the 15% temporary tariff level from 24/2/26 for an initial 150 days, except on some goods such as critical metals, minerals, and pharmaceutical products. USMCA-compliant goods from Canada and Mexico are also exempted.   Episode Sections: 00:23 – Introduction to Recent Tariff Changes 02:48 – Reimbursement for Importers 03:46 – New Tariff Plans and Manufacturing Uncertainty 07:54 – Concerns Over the US Dollar 08:57 – Upcoming Webinar Announcement 09:44 – Wrap-up   Related content… Supreme Court rules Trump's tariffs illegal - CNN Supreme Court Trump tariff decision impact: What to expect as fight for billions in refunds begins - CNBC Trump raises tariffs to 15% on imports from all countries - The Guardian   Confused about how the latest tariff news will affect your business? On February 25 at 11 AM Eastern Time, there will be a free online panel that YOU can join for free, "Refining Your Global Supply Chain Strategy," with Renaud's business partner, Agilian CEO Fabien Gaussorgues. The panel will provide insights on global supply chain and manufacturing strategies for companies that sell products in the USA market. In it, they'll explain the current situation, the very recent changes and what that may mean for importers. The signup page is here:  https://docs.google.com/forms/d/e/1FAIpQLSeeDT_BUwqxJPxCy7pKXd8kyFgDh0QiUSiXXbmb0mTkIzejPg/viewform Get in touch with us Connect with us on LinkedIn Contact us via Sofeast's contact page Subscribe to our YouTube channel Prefer Facebook? Check us out on FB

Charles Bernard is the Chief Economist at the Canadian Automobile Dealers Association. Learn more about your ad choices. Visit megaphone.fm/adchoices

From reimbursements to inventory management, independent pharmacists face ongoing pressure to optimize the financial health of their business. In this episode, Jean Paul Gibeault, PharmD, RPh of Atlantic Health System shares how their two retail pharmacies have maintained strong financial performance using solutions like Cardinal Health™ Reimbursement Consulting Services (RCS). He discusses how real-time intelligence and a robust analytics and consulting platform can transform a pharmacy's bottom line.  Listen to uncover financial strategies that can help boost revenue and expand patient reach while upholding an unwavering commitment to quality, community care. 

In this episode of Medsider Radio, we sat down with Shaun Bagai, CEO of RenovoRx. The company is developing targeted oncology therapies and is currently commercializing RenovoCath, which is focused on pancreatic cancer. Before joining RenovoRx in 2014, Shaun spent over a decade in the cardiovascular space, including leading global market development at HeartFlow and helping establish the European renal denervation market at Ardian, which Medtronic acquired for approximately $1 billion. He began his career in clinical research and device sales at TransVascular and Medtronic. In this interview, Shaun discusses how testing markets with minimal infrastructure reveals what leads to commercial success, why clinical trial enrollment benefits from sales discipline, and what founders should understand about going public when traditional capital isn't available.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Shaun Bagai.

From reimbursements to inventory management, independent pharmacists face ongoing pressure to optimize the financial health of their business. In this episode, Jean Paul Gibeault, PharmD, RPh of Atlantic Health System shares how their two retail pharmacies have maintained strong financial performance using solutions like Cardinal Health™ Reimbursement Consulting Services (RCS). He discusses how real-time intelligence and a robust analytics and consulting platform can transform a pharmacy's bottom line.  Listen to uncover financial strategies that can help boost revenue and expand patient reach while upholding an unwavering commitment to quality, community care. 

Digital health is no longer in its honeymoon phase. The funding boom is over. AI hype is everywhere. Health systems are overwhelmed. And startups can no longer survive on compelling pitch decks alone. In this episode of Faces of Digital Health, Tjaša Zajc speaks with Ruchi Dass, a former dental surgeon turned public health leader, policy contributor, investor, and advisor to startups scaling across the US, UK, India, Africa, and the Middle East. Ruchi describes a fundamental change in go-to-market (GTM) strategy: Workflow integration is non-negotiable (standalone apps struggle). Reimbursement clarity is critical. Regulatory strategy is part of GTM, not an afterthought. Time stamps: 00:06 – Introduction: startups, global markets, and unconventional careers 01:18 – From dental surgery to global public health and digital health 03:05 – The GTM shift: from promise to proof 04:49 – Staying investable: the four pillars 08:22 – AI ROI: clinical vs operational value 12:17 – Enterprise scaling and “sell to the mindset” 15:05 – Responsible AI: transparency, bias, and lifecycle regulation 19:56 – Predictability vs black-box AI in medicine 22:44 – Global innovation differences: Europe, India, Middle East, Africa 26:21 – Pilotitis: why pilots fail to scale 28:40 – Designing pilots for commercialization 30:26 – Capital flows, geopolitics, and reverse innovation 34:25 – The $1 teleconsultation model in India 37:56 – Digital health and equity: design vs digitization 42:43 – How regulators can keep up with AI 46:03 – Advice for Gen Z and Gen Alpha in digital health 48:50 – Grassroots realities shaping policy Watch the full discussion: https://youtu.be/bmvPzz3Ffp4 www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/

In this episode, Melissa Majerol, Model Lead of the Cell and Gene Therapy Access Model at the Center for Medicare and Medicaid Innovation (CMMI) at CMS, breaks down how the CMMI Access Model program aims to simplify and accelerate patient access to innovative cell and gene therapies, starting with recently approved therapies in Sickle Cell disease. Listen in as we dive into the specifics of this new access model and its current status. Music: ‘Bright New Morning’ by Steven O’Brien – released under CC-BY 4.0. https://www.steven-obrien.net/Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

In this episode of Medsider Radio, we sat down with Justin Zenanko, co-founder & CEO of SynerFuse.SynerFuse is developing the e-TLIF procedure, which combines spinal fusion with neuromodulation by placing leads directly at exposed nerves during surgery.A certified public accountant and serial entrepreneur, Justin previously served as CFO and senior vice president of corporate development at Recombinetics, where he led fundraising efforts totaling $68 million.In this interview, Justin discusses approaching FDA interactions as negotiations, validating procedures with off-the-shelf components before investing in custom devices, and structuring private raises through investment banks to preserve control while delaying institutional venture capital.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Justin Zenanko.

On this episode of The Military Millionaire Podcast, I am sharing the ultimate no-BS playbook to help you navigate the chaos of a Permanent Change of Station (PCS). My inbox is constantly blowing up with questions from service members who are stressed, confused, and getting screwed by the system during their moves. I break down exactly how to structure your move—from leveraging partial PPMs to mastering the finance office—so you can avoid paying out of pocket. We also cover practical packing hacks and the critical "do not pack" room strategy to protect your valuables. By following this guide, you will make your next move smoother, cheaper, and potentially even profitable.   Timestamps (00:00) - Intro (01:44) — Know your PCS entitlements (02:04) — Build a PCS binder (03:12) — Video inventory walkthrough (06:12) — Do-not-pack room strategy (09:57) — Track inventory spreadsheet (15:01) — Receipt tracking reimbursements   About the Show On the Military Millionaire Podcast, I share real conversations with service members, veterans, and their families. Each week, we explore how to build wealth through personal finance, entrepreneurship, and real estate investing. Resources & Links Download a free copy of my book: https://www.frommilitarytomillionaire.com/free-book Sign up for free webinar trainings: https://www.frommilitarytomillionaire.com/register Join our investor list: https://www.frommilitarytomillionaire.com/investors Apply for The War Room Mastermind: https://www.frommilitarytomillionaire.com/mastermind-application Get an intro to recommended VA agents/lenders: https://www.frommilitarytomillionaire.com/va-realtor Guide to raising capital: https://www.frommilitarytomillionaire.com/capital-raising-guide   Connect with David Pere Facebook Group: https://www.facebook.com/groups/militarymillionaire YouTube Channel: https://www.youtube.com/@Frommilitarytomillionaire?sub_confirmation=1 Instagram: https://www.instagram.com/frommilitarytomillionaire/ LinkedIn: https://www.linkedin.com/in/david-pere/ X (Twitter): https://x.com/militaryrei TikTok: https://www.tiktok.com/@militarymillionaire

On this episode of SurgOnc Today, Dr. Zhi Ven Fong discusses with Dr. Christopher Childers, Dr. Erin Strong, Dr. Udai Sibia, & Dr. David Litvak, what surgical oncologists should know about value-based care and how it impacts their practices. The speakers also touch on real-world examples and detail how surgical oncologists can take an active role in optimizing value-based care within their hospital and health systems.

Steve Tafoya takes a dive deep into a new bill aimed at transforming treatment-in-place capabilities and establishing Medicare reimbursement models tailored for emergency medical providers. Drawing on 25 years of frontline experience and a strong legal and business background, Steve sheds light on the current reimbursement challenges EMS agencies face, with only about 14-25% of calls being fully reimbursed. The discussion highlights how this legislation could reshape EMS's role beyond traditional 911 response—integrating community health, alternative destinations, and innovative care models. Steve emphasizes the critical need for provider voices in lawmakers' offices and urges industry stakeholders to engage with representatives to support this bill. The podcast also explores the expanding career opportunities in EMS, including agency response units and industrial medical teams.

In this episode of Medsider Radio, we sat down with Marina Pavlovic Rivas, co-founder & CEO of Eli Health.The company is focused on making hormone data accessible in real time through its saliva-based testing system that delivers results through a mobile app. A data scientist by training, Marina previously founded Gradiant AI, a machine learning company that was acquired in 2019. In this interview, Marina discusses how to evaluate form factor options without locking into a design too early, what beta testing reveals that years of lab work can't, and how existing consumer spending patterns influence positioning and pricing strategies. She also shares how regulatory considerations shaped product decisions from the outset and why building in-house proved more efficient than outsourcing when external partners said the company's goals were impossible.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Marina Pavlovic Rivas.

In this special episode recorded live at Graham Sessions, Jimmy talks with clinic owner Mike Reing and Marymount University DPT Dean Skye Donovan about what's broken in the profession — and what it'll take to fix it.You'll hear:Why clinic owners are frustrated with declining reimbursementHow to actually hire and retain new gradsThe divide (and opportunity) between academics and businessWhat PT education needs to teach that it currently doesn'tWhy optimism still matters — and how to find itWhether you're a student, academic, or clinic owner, this conversation hits on the real tension — and the real possibilities — in PT today.???? Resources & LinksMarymount DPT Program: https://marymount.eduUSPH Careers: https://usphcareers.comBrooks IHL: https://brooksihl.orgEmpower EMR: https://www.empoweremr.com????️ Sponsors:Pre-Roll: Empower EMR → “Upgrade your clinic's brain with EMPOWER EMR. Better notes, smoother workflows, and support that doesn't ghost you.” → https://www.empoweremr.comMid-Roll: U.S. Physical Therapy → “Leadership tracks, mentorship, and career growth — all in a national network built for PTs.” → https://usph.comPre-Parting Shot: Brooks IHL → “Residencies, fellowships, and CE that shape better clinicians — not just give you letters.” → https://brooksihl.org

The Cool Fireman Podcast | Featuring Matt, Brian, Doug Bishop, and Unkie (Adam)Episode summaryEpisode 143 starts with classic pre-show chaos (tech issues + “Instagram crushing”), then pivots into a real-deal conversation about upstaffing—why it matters, how it's triggered, what it looks like across the country (snow/ice, hurricanes, wildfires), and the hardest part of emergency operations: deciding when you can't respond. The crew also hits sponsor updates, a powerful moment of silence request, and finishes strong with Snail Mail—highlighting promotion motivations and a listener question about leading with love from the back seat.NEW MERCHANDISE STORE:https://the-cool-fireman.myshopify.com/collections/all14:40 – Moment of silence (LODD / cancer-related death)A listener email from Tyler Adams requests recognition of David Hendricks, Crescent VFD (Crescent, Texas), who died from job-related cancer (email dated Jan 15). The crew honors him with a moment of silence and discusses the continuing impact of occupational exposure and long-term health effects.Main discussion: Upstaffing (what it is + why it matters)20:20 – What triggers upstaffing?Doug breaks down winter storm operations: snow/ice projections, above-ground power lines, down trees, stuck units, and how departments decide to add resources.Storm readiness checklist & resources72/48/24-hour storm checklists“Storm boxes” / totes with required itemsInstant chains, Z-cables, heavy chains (deep-snow thresholds, speed limitations)Brush trucks + MSU/ambulance support + occasional snow plow attachmentsParks/forestry departments helping with non-powerline tree calls28:40 – Hurricane realities & hard decisionsBrian shares hurricane lessons learned: evacuations, resource shortages, and what happens when response becomes physically impossible. The crew talks about the public expectation of “they'll come” vs the operational reality of risk assessments and responder safety.34:10 – The hardest callBrian and Doug hit the human element:deciding to stop dispatching during severe conditions is one of the most mentally draining decisions in a career.38:00 – Mandatory vs volunteer upstaffingDoug explains how their staffing system pushes out texts/emails and how, if needed, upstaffing becomes mandatory—especially when conditions demand it.41:10 – EOC + finance side (FEMA reimbursement)Brian outlines how disaster declarations and documentation flow through local/state/federal layers and why accurate documentation is essential for:overtime reimbursementresource requestsbudget survival after repeated disastersHe also notes current conversations around FEMA process changes due to bureaucratic delays.49:20 – West Coast comparison: wildfire “upstaffing” via pre-positioningMatt explains how CA handles wildfire readiness: red flag pre-positioning, North Ops/South Ops strike team staging, OES resources, and “Ready, Set, Go” evacuation messaging.50:50 – Post-incident notes (critical takeaway)Brian recommends crews capture notes after each operational period to support post-incident critique and justify future staffing/tools.Snail Mail (listener highlights)Zach's take on promotionsStay at the level you're passionate about. Promotion for title/pay increases risk when leadership lacks heart and preparation.Colt's question: “How do you lead with love riding backwards?”Matt shares Pastor Joby Martin's definition:Love is my joy in the Lord expressed toward others at great expense to myself. Calls to actionJoin Patreon: Rookie ($1) / Engineer ($2) for extra content + Turnout Drill opportunitiesSubmit a Moment of Silence request: email coolfireman @ gmail.comSnail Mail: drop comments/questions on Spotify—your message may be featuredStay engaged: support legislative efforts affecting firefighter safety, cancer research, and operational risk

January 23 , 2026 In this episode, Scott and Mark Painter discuss what the upcoming January 31 deadline means for telehealth coverage under Medicare, including expectations around funding extensions, potential payment delays, and bipartisan support for long-term access. They also introduce the expanded PRS Coding and Reimbursement Hub—an evolving resource offering disease-specific coding guides, product-specific reimbursement tools, prostate biopsy calculators, EOB insights, and more. Designed to help practices stay ahead of payer policy shifts and streamline claims for new technologies, the Hub is positioned to become urology's go-to coding and reimbursement resource in 2026 and beyond.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss 2026 trends. Together, they explore:  JP Morgan Healthcare Conference (00:34): Dr. Morice shares his top observations and takeaways after attending this year's conference. Artificial intelligence (06:02): Anticipated benefits and risks of AI developments predicted in 2026.Reimbursement and regulation (13:43): Why reimbursement and regulation continue to be areas of significant interest in clinical diagnostics. Note: Information in this post was accurate at the time of its posting.ResourcesTransforming laboratory medicine through AI: From promise to practice"Answers From the Lab" podcast: Breakthroughs and Trends That Defined Lab Medicine in 2025"Answers From the Lab" podcast: PAMA Update and Accelerating Research and Development With BioPharma Diagnostics

In Episode 77 of the WeInfuse Podcast, we welcome back Trey Holterman from Tennr for a timely and practical conversation on how to create a reliable referral-to-treatment process in today's increasingly complex healthcare environment. Trey returns following his earlier appearance on Episode 69: How to Improve Efficiency, Reimbursement & Service with Trey Holterman where he explored how automation and workflow optimization can help infusion centers process patients faster and improve reimbursement outcomes, where he discussed improving efficiency, reimbursement, and service across patient intake workflows. In this follow-up episode, the conversation goes deeper, focusing on where referrals break down, why patients get stuck, and how operational gaps at the front end create downstream problems for patients, staff, and revenue. Trey shares the most common points of failure between referral and treatment, including incomplete orders, slow outreach, unclear financial responsibility, and prior authorization delays. Trey also breaks down what many operators experience every year but struggle to manage effectively, the insurance “blizzard.” As insurance changes reset at the start of the year, infusion centers face a surge of eligibility checks, authorization reviews, and documentation updates. When these steps are not handled proactively, patients show up for care only to be turned away, or worse, receive treatment that will never be reimbursed. Listeners will gain insight into how speed, structure, and clarity at the front end of the process directly impact patient conversion, denial rates, staff workload, and risk exposure. Trey shares real-world examples of how tightening referral intake, standardizing prior authorization workflows, and proactively managing insurance changes can dramatically improve both patient experience and operational performance. This episode is a must-listen for infusion center leaders, operators, and referral teams who want to reduce chaos, protect revenue, and ensure patients move smoothly from referral to treatment without falling through the cracks.

In this episode of Medsider Radio, we sat down with Greg Walters, co-founder & CEO of Excision Medical. Excision is developing a leaflet modification system to enable lifetime management of aortic stenosis.Greg has almost 40 years of experience in cardiovascular devices, holding leadership roles at Kensey Nash Corporation where he led the development of Angio-Seal and several endovascular programs. He later co-founded Essential Medical, which was acquired by Teleflex in 2018, and is an inventor on more than 75 U.S. and European patents.In this interview, Greg discusses why early-stage teams should build to learn rather than to impress, using functional prototypes to generate real feedback and fundraising momentum. He outlines how disciplined safety work — not perfection — defines first-in-human readiness, and what makes a pre-revenue company attractive to strategic acquirers. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Greg Walters.

This episode features one of the most raw, real, and insightful convos we've had on the future of physical therapy.Jimmy sits down with Dave Kittle and Tony Maritato to cover everything clinic owners need to hear right now:Why PTs are still trapped in outdated reimbursement modelsHow to build a cash-based membership that actually worksSliding into DMs to recruit A+ hiresEMRs that suck (and why they still do)The real problem with AI in healthcareWhy some PT leaders still won't talk about what matters mostIf you've ever yelled at your EMR, questioned your payer mix, or thought about quitting insurance cold turkey — this one's for you.

(The Center Square) – As ongoing controversy persists over alleged fraud with Department of Children, Youth & Families Working Connections Childcare Program, Gov. Bob Ferguson's proposed 2026 supplemental operating budget could increase the reimbursement rates for licensed home-based child care providers by 30%.Support this podcast: https://secure.anedot.com/franklin-news-foundation/ce052532-b1e4-41c4-945c-d7ce2f52c38a?source_code=xxxxxx Read more: https://www.thecentersquare.com/washington/article_0c79cfe6-7b01-4960-b901-599f84df051c.html Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of the Vital Health Podcast, host Duane Schulthess speaks with two experts on reimbursement-facing evidence questions for accelerated oncology approvals at ISPOR Europe 2025 in Glasgow, Scotland: Anja Schiel: Senior Advisor, Norwegian Medical Products Agency Niklas Hedberg: Chief Pharmacist at The Dental and Pharmaceutical Benefits Agency (TLV) They unpack why results that are strong inside a clinical trial can be harder to apply to real-world national populations, how decision-makers weigh patient-relevant outcomes and uncertainty at the time of access decisions, and what risk management can look like when early approvals require follow-up evidence and potential reassessment. Key Topics: Trial Generalizability: Selection in trials, real-world populations, and health system variation. Reimbursement Evidence: Patient-relevant outcomes, absolute versus comparative benefit, small-sample challenges. Conditional Approval: Evidence at authorization, reassessment expectations, withdrawal, and restriction risk. Risk Tradeoffs: Approving too early versus delaying access, urgency in progressive disease, and equity constraints. Adaptive Follow-up: Real-world evidence plans, managed entry approaches, learning while treating. Opinions expressed are those of the speakers. This podcast was supported by Merck Sharp & Dohme as part of the APACE project, in collaboration with GlaxoSmithKline and AstraZeneca.See omnystudio.com/listener for privacy information.

In this episode of Medsider Radio, we sat down with Jaeson Bang, Founder & CEO of Future Cardia. Future Cardia is developing a subcutaneous heart-failure monitoring platform designed to capture both electrical and mechanical cardiac signals through a simple office-based procedure.Jaeson brings more than two decades of experience building implantable cardiac technologies across Medtronic, CVRx, EBR Systems, and Abiomed. Drawing on that background, he questioned industry assumptions around miniaturization and invasive workflows — and built a device that prioritizes performance, durability, and clinical practicality instead.In this interview, Jaeson shares how challenging a core constraint unlocked a faster development path, why deep domain expertise matters more than thrift in regulated markets, and how raising capital outside traditional VC can preserve leverage and buy time.If you'd rather read than listen, here's a link to the full interview with Jaeson Bang.

Terry kicks off 2026 by clearing up a major misunderstanding in the provider and manufacturer community. Some believed that CMS's last‑minute withdrawal of the LCD for skin substitute products would delay or stop the 2026 reimbursement changes. That's not the case. The LCD withdrawal has no impact on the Final Rule, and the new 2026 reimbursement methodology for skin substitutes will move forward exactly as finalized, using an incident‑to payment structure. In this episode, Terry breaks down the difference between the policy halt and the reimbursement rules, and explains what providers need to know about the updated approach to skin substitutes and skin graft products and services. Subscribe and Listen You can subscribe to our podcasts via: Apple Podcasts – https://podcasts.apple.com/us/podcast/codecast-medical-billing-coding-insights/id1305926627 Spotify – https://open.spotify.com/show/1lA69Q7EnjSMuVr3sXVWlX TuneIn – https://tunein.com/radio/CodeCast–Medical-Billing-p1056702/ YouTube – https://www.youtube.com/channel/UCoNm5vs6PFMIEDa5Undidlg YouTube Music – https://www.youtube.com/playlist?list=PLQ8tk23yZroZslhtTVe-PEIjQsAoJZJIQ Pandora – https://www.pandora.com/podcast/codecast-medical-billing-and-coding-insights/PC:1000156874 Amazon Podcasts – https://music.amazon.com/podcasts/c9d8dc99-fced-45a2-82b4-0efdf144c897/CodeCast-Medical-Billing-and-Coding-Insights iHeart Radio – https://www.iheart.com/podcast/256-codecast-medical-billing-a-31135434/ The post Skin Substitutes and Grafts LCD vs Reimbursement 2026 appeared first on Terry Fletcher Consulting, Inc..

3rd Party Reimbursement with Clark Simpson

The vision for Optum Real is to create real-time transparency between payers and providers in the moments of care that matter. Current AI technology, according to Puneet Maheshwari, SVP, GM of Optum Real is making this possible now.Optum is a major force in health care, serving nine out of ten health care systems and four out of five payers in the U.S. Optum Real is in pilot now with a number of health care organizations. During the pilot, the platform has achieved a 25% reduction in call volume in the first two weeks with one health care provider, a 42% reduction at another, and a reduction in errors in reimbursement submissions of up to 75% with a large health system in Minnesota.Learn more about Optum Real: https://business.optum.com/en/operations-technology/optum-real.html Healthcare IT Community: https://www.healthcareittoday.com/

DEAR PAO: A builder in bad faith loses that which he built without indemnity or reimbursement | Dec. 23, 2025Subscribe to The Manila Times Channel - https://tmt.ph/YTSubscribeVisit our website at https://www.manilatimes.net Follow us: Facebook - https://tmt.ph/facebook Instagram - https://tmt.ph/instagram Twitter - https://tmt.ph/twitter DailyMotion - https://tmt.ph/dailymotion Subscribe to our Digital Edition - https://tmt.ph/digital Check out our Podcasts: Spotify - https://tmt.ph/spotify Apple Podcasts - https://tmt.ph/applepodcasts Amazon Music - https://tmt.ph/amazonmusic Deezer: https://tmt.ph/deezer Stitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes#KeepUpWithTheTimes Hosted on Acast. See acast.com/privacy for more information.

Insurance can be frustrating to figure out on your own. In this episode, Kirk Behrendt brings back Shelley DeGroff, founder of PPO Advisors, to decode some of the biggest changes in the PPO world and share two things you need to do to improve your reimbursements in the upcoming year. To stay up to date with PPO changes and prevent future revenue loss, listen to Episode 983 of The Best Practices Show!Learn More About Shelley:Send Shelley an email: shelley@ppoadvisors.com Join PPO Advisors on Facebook: https://www.facebook.com/PPOAdvisorsLLCLearn more about PPO Advisors: https://ppoadvisors.comMention this episode or visit this link to receive $500 off your analysis fee: https://learn.ppoadvisors.com/promoMore Helpful Links for a Better Practice & a Better Life:Subscribe to The Best Practices Show: https://the-best-practices-show.captivate.fm/listenJoin The Best Practices Association: https://www.actdental.com/bpaDownload ACT's BPA app on the Apple App Store: https://apps.apple.com/us/app/best-practices-association/id6738960360Download ACT's BPA app on the Google Play Store: https://play.google.com/store/apps/details?id=com.actdental.join&hl=en_USJoin ACT's To The Top Study Club: https://www.actdental.com/tttGet The Best Practices Magazine for free: https://www.actdental.com/magazinePlease leave us a review on the podcast: https://podcasts.apple.com/us/podcast/the-best-practices-show-with-kirk-behrendt/id1223838218Episode Resources:Watch the video version of Episode 983: https://www.youtube.com/@actdental/videosWatch Episode 954 with Shelley DeGroff: https://www.youtube.com/watch?v=ZjJ6cLq_k50Main Takeaways:Stay on top of your EOBs by auditing them regularly.Evaluate your master fee to ensure you're paid what you're owed.Learn what stacking order means and how it can affect your practice.Opt-outs are not automatic! Be proactive so they are processed correctly.You don't need to be 100% PPO or 100% fee-for-service. Have a healthy mix.Don't get complacent or comfortable. Understand the contracts you're agreeing to.Snippets:0:00 Introduction.1:16 Shelley's background.2:10 A refresher on important PPO changes.7:15 Audit your EOBs regularly.10:23 Master fee, explained.17:29 Stacking order, explained.20:55 How PPO...

In this episode of Medsider Radio, we sat down Dr. Adam Kadlec, practicing urologist and co-founder of Rivermark Medical.Rivermark is a clinical-stage company developing FloStent, a first-line, reversible device therapy for benign prostatic hyperplasia (BPH).Before launching Rivermark, Adam built a thriving urological practice in Milwaukee and consulted for several device companies — experiences that ultimately revealed how early true device development begins and why physicians rarely get the chance to influence innovation upstream. Partnering with medtech operator Andy Doraiswamy, Adam transitioned from clinician to CEO and is now leading Rivermark through its pivotal trial.In this interview, Adam shares why workflow integration is one of the most overlooked drivers of adoption, how physician-innovators can build the right decision-making infrastructure, and why understanding who actually enrolls patients at clinical sites can make or break a trial. He also touches on the mindset required to stay resilient through the ups and downs of building a medtech startup.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Adam Kadlec.

December 12, 2025 In this episode, Scott, Mark, and Ray Painter share highlights from the recent Urology Advanced Coding and Reimbursement Seminar in Las Vegas, including robust discussions on E/M coding, prostate biopsy changes, modifiers, and the Wiser program. They also provide an important update on the AMA's recent meeting about coding and payment for algorithmic services, detailing how CPT and the RUC are approaching AI integration in healthcare. From potential reimbursement models to risk assignment and FDA considerations, this forward-looking conversation covers the groundwork being laid for AI's role in clinical care and payment policy.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

PointClickCare is a major EHR service with a 25-year history, originally focused on post-acute care settings such as skilled nursing and assisted living but has expanded to provide health it services to the full spectrum of healthcare provider organizations.  As they've expanded their services, one of the areas they wanted to help was care transitions between acute care and post acute care and back. After a two-year investment in AI, they've enhanced the services they offer to make transitions go more smoothly and intelligently.Plus, they have recently unveiled a service named Chart Advisor within their skill nursing EHR. It looks through freeform documentation such as progress notes to find important information that isn't in the structured fields and could have an immediate impact on care. For instance, if the patient had a fall in the hospital, have the doctors performed the necessary assessments and accommodations to prevent more falls?According to Chief Revenue Officer Brian Drozdowicz, who we interviewed at the HLTH conference, searches through plain text documentation can help with both liability and reimbursement.  Leveraging technology to search and sort through all the unstructured data in documentation is really the key to improving care and revenue.Learn more about PointClickCare: https://pointclickcare.com/Healthcare IT Community: https://www.healthcareittoday.com/

In September, Irish businessman Paul Anthony Walsh was shocked to find that thousands had been stolen from his Revolut account.He has now been told by Revolut that he is not entitled to a reimbursement.He joins Andrea to discuss what exactly happened. Presenter of the Home Show on Newstalk and Consumer Columnist with the Irish Independent, Sinead Ryan also joins to discuss how to avoid these types of scams.

In this episode of Medsider Radio, we sat down with Andrew Holman, MD, CEO of Inmedix. Inmedix is commercializing CloudHRV, an FDA-cleared diagnostic that quantifies biological stress with clinical precision to guide treatment decisions in autoimmune disease and beyond.Andrew is a practicing rheumatologist in Seattle with 25 years of clinical and research experience. His discoveries linking autonomic dysfunction to autoimmune disease outcomes led to a $10 million patent sale to Boehringer Ingelheim. After a decade in retirement, he returned to found Inmedix and pioneer the field of immuno-autonomics — preparing the market for his technology years before launch.In this interview, Andrew shares how to build a category before commercializing a product, why clinical evidence creates competitive moats that money can't replicate, and how to raise capital from angel investors by understanding what they actually care about.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Andrew Holman.

Rural Health News is a weekly segment of Rural Health Today, a podcast by Hillsdale Hospital. News sources for this episode: American Hospital Association, “AHA, other file suit to block unlawful 340B changes threatening patient care,” December 1, 2025, https://www.aha.org/news/headline/2025-12-01-aha-others-file-suit-block-unlawful-340b-changes-threatening-patient-care. Bridget Early, “Home health providers hit with Medicare pay cut,” December 1, 2025, https://www.modernhealthcare.com/politics-regulation/mh-medicare-home-health-pay-2026-cms/#, Modern Healthcare. Celli Horstman, Arnav Shah, “The State of Rural Primary Care in the United States,” November 17, 2025, https://www.commonwealthfund.org/publications/issue-briefs/2025/nov/state-rural-primary-care-united-states?mkt_tok=NzEwLVpMTC02NTEAAAGeOB9y6SbuBxye3wQ7igjy1BVe5GMJxaV9fCloFJmQfS-T6mbVfjH7QWw88rhSoHiy3G1b3YS0OFamdkSiphiBb7XyLWJP3BOoGozzQcWDe1J4qOk, The Commonwealth Fund. Erica Cerutti, “The state of rural primary care: 4 notes,” November 19, 2025, https://www.beckershospitalreview.com/quality/hospital-physician-relationships/the-state-of-rural-primary-care-4-notes/, Becker's Clinical Leadership. Rural Health Today is a production of Hillsdale Hospital in Hillsdale, Michigan and a member of the Health Podcast Network. Our host is JJ Hodshire, our producer is Kyrsten Newlon, and our audio engineer is Kenji Ulmer. Special thanks to our special guests for sharing their expertise on the show, and also to the Hillsdale Hospital marketing team. If you want to submit a question for us to answer on the podcast or learn more about Rural Health Today, visit ruralhealthtoday.com.

For many of us, payer negotiations feel distant—something handled “somewhere up the chain,” far removed from the day-to-day work of helping patients. But here's the truth: nothing shapes our practice more than the reimbursement rates and contracts negotiated on our behalf.Reimbursement determines who we can serve, how much time we can spend with them, what services we can sustainably provide, and ultimately whether our practice can survive/thrive. And while therapists may assume this is a job for billing or leadership, every OT and PT needs a foundational understanding of how payer negotiations work.In this one-hour webinar, we're joined by two leaders with deep, real-world expertise:John Hutchinson, MBA — Co-founder of CARE Counseling (with his wife, Dr. Andrea Hutchinson), a practice acquired by UnitedHealth in 2024. John brings firsthand experience navigating growth, payer relationships, and the business realities that shape modern care.Chad Herzog — VP of Operations at Aroris, an organization whose mission is simple and powerful: help healthcare providers get paid what they're worth so they can focus on what matters most—helping people and improving patients' lives.Together, they'll break down what every clinician should know about payer negotiations, how reimbursement impacts clinical practice, and what therapists can do to advocate for sustainable care models.See full course details here: https://otpotential.com/ceu-podcast-courses/negotiating-with-payersSee all OT CEU courses here: https://otpotential.com/ceu-podcast-coursesSupport the show by using the OTPOTENTIAL Medbridge Code: https://otpotential.com/blog/promo-code-for-medbridgeLearn about Aroris and payer contract negotiation: https://www.arorishealth.com/contract-negotiation/Try 2 free OT Potential courses here: https://otpotential.com/free-ot-ceusSupport the show

In this episode of Medsider Radio, we sat down with Colby Holtshouse, President and CEO of May Health.May Health is developing a minimally invasive ovarian ablation therapy designed to restore ovulation in women with polycystic ovary syndrome (PCOS) and PCOS-related infertility.Before May Health, Colby served as Global Medtech Commercial Lead at Organon, overseeing the worldwide launch of the Jada System following Organon's acquisition of Alydia Health, where she held roles including COO, Interim CEO, and VP of Marketing. She has also held leadership positions at Pelvalon, AccessClosure, Medtronic, and Guidant.In this discussion, Colby shares why early clinical evidence should be built in focused layers rather than oversized, all-at-once trials. She explains how a small, deliberate early launch can reveal the workflow nuances and real-world expectations no study ever captures. And she outlines why founders should define the raise first — and how clarity, preparation, and a deep understanding of strategic partners can dramatically accelerate the fundraising process.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Colby Holtshouse.

How economically viable is gynecologic surgery today, and what happens if the system keeps pushing the limits? In this episode of BackTable OBGYN, Dr. Marisa Dahlman from Virginia Mason in Seattle sits down with hosts Mark Hoffman and Dr. Amy Park to discuss the evolving landscape of this field and the pressures surrounding reimbursement. --- SYNPOSIS Dr. Dahlman begins by sharing her career path and fellowship experience before the conversation expands to explore the shift from MIGS (Minimally Invasive Gynecologic Surgery) to CBG (Complex Benign Gynecology), current reimbursement challenges, the difficulty of balancing obstetric and gynecological practice, and how these forces influence training and clinical life. They also discuss the stressors new graduates face while building viable practices, broader healthcare system challenges, resource allocation, and potential solutions to improve practice sustainability and patient care. --- TIMESTAMPS 00:00 - Introduction 03:06 - Fellowship Training and Career Pathways11:43 - Impact of Reimbursement on Fellowship Applications15:20 - Workforce Issues and Future of GYN Surgery28:02 - Advocacy and Leadership in Healthcare29:27 - Understanding Hospital Revenue and Efficiency31:54 - The Role of Physician Leadership in Healthcare35:35 - Navigating Healthcare System Mergers36:47 - The Future of Healthcare Amidst Financial Cuts41:40 - Addressing Healthcare Costs and Reimbursement45:11 - The Importance of Women's Health Services47:37 - Strategies for Improving Healthcare Systems53:48 - Concluding Thoughts --- RESOURCES Trends in gynecologic surgery reimbursement and physician payhttps://pubmed.ncbi.nlm.nih.gov/40305043/

In this episode of Disruption/Interruption, host KJ interviews Matt Seefeld, CEO at MedEvolve, about the chaos and inefficiencies in the US healthcare revenue cycle. Matt shares how generative AI and a focus on human accountability can help providers achieve "zero touch" claims, reduce waste, and improve access to care, especially for small and rural hospitals. Four Key Takeaways: The Real Cost of Healthcare is Obscured (3:00)The US healthcare system lacks alignment between consumers, providers, and payers, making it nearly impossible to know the true cost of care. Administrative Waste is a Billion-Dollar Problem (04:01)Most providers touch claims multiple times, with 63% of those touches being wasted effort due to system inefficiencies and payer games. AI is a Tool, Not a Cure-All (31:50)While AI can automate and improve processes, more than half of claim errors still require human intervention, and technology alone won't solve systemic issues. Access to Care is Shrinking for Many Americans (24:00, 27:00)As costs rise and reimbursements fall, small and rural hospitals are closing, and more Americans are forced to seek care through emergency services or go without. Quote of the Show (31:50):"More than half—53%—of the errors that we see that humans have to get involved with come from AI solutions, so they're not smart enough yet." - Matt Seefeld Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Matt Seefeld: LinkedIn: https://www.linkedin.com/in/matt-seefeld-521319/ Company Website: https://medevolve.com How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

In this episode of Medsider Radio, we sat down with Kaitlin Maier, co-founder and CEO of Reia. Reia has developed a self-managed pessary — a collapsible device that empowers women to treat pelvic organ prolapse comfortably and independently. A mechanical engineering graduate of Dartmouth, Kaitlin previously worked at Sherpa Technology Group, developing patent strategies for leading life science and technology firms. In this conversation, Kaitlin shares how she and her co-founders turned a student project into an FDA-cleared product using resource constraints as a design advantage. She explains how to turn FDA feedback into forward momentum, why running an NIH-funded randomized controlled trial (RCT) strengthened both credibility and confidence, and how non-dilutive funding can buy the time and control founders need to build on their own terms.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Kaitlin Maier.

In this powerful conversation, Will and long-time friend Dr. Dimitrios Kostopoulos dive deep into the most critical challenges facing physical therapy private practice owners today: low reimbursement rates and the crippling staffing and recruitment crisis.Dr. Kostopoulos shares the origin story of HODS, revealing the "ultimatum letter" in 2002 that forced him to pivot from being an "effect" to a "cause" in his own business. The discussion highlights the unsustainable disparity in reimbursement between private practices and large hospital organizations, and how this directly fuels the current struggle for talent and profitability.What You'll Learn:The two major themes causing PT burnout and the industry's "massive exodus."Dr. Kostopoulos' powerful advocacy plan for the APTA to lobby for an exemption of the $$100,000$ H-1B visa fee for physical therapists to solve the immediate staffing shortage.The three ways any private practice can grow their bottom line, and why cutting expenses is the lowest-yield activity.Will's proven, high-yield solution to the staffing and time crisis: Virtual Assistants (VAs).Why Dr. Kostopoulos and his partner sold the physical therapy component of their organization to focus on diagnostic testing and industry education through HADS.A combined final takeaway: The importance of hope, action, and refusing to live in the "zone of maybe."This is an essential listen for any private practice owner looking for actionable strategies to improve profit, gain time, and secure the future of their practice.Send us a textVirtual Rockstars specialize in helping support or replace all non-clinical roles.Learn how a Virtual Rockstar can help scale your physical therapy practice.Subscribe here to our completely free Stress-Free PT Newsletter for your weekly dose of joy.

In this episode of Medsider Radio, we sat down with Somer Baburek, CEO and co-founder of Hera Biotech. Hera is developing AI-driven tissue diagnostics for conditions that disproportionately affect women, including endometriosis and cervical cancer.Before launching Hera, Somer spent nearly a decade in venture capital, where she evaluated early-stage medtech startups and learned what separates the survivors from the rest.In this conversation, Somer explains how Hera designed global clinical pathways that balance cost and credibility, why boutique CROs can outperform big names, and how a pre-commercial startup completed three strategic acquisitions using equity and brand trust rather than cash.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Somer Baburek.

As dental professionals, we often focus solely on dental insurance reimbursements, yet many procedures qualify for coverage under medical insurance. By understanding how to articulate the medical necessity of certain dental treatments, dentists can not only enhance patient care but also unlock additional revenue streams. Joining us is our guest Kandra Sellers. Kandra is a RDH with over 25 years in the dental industry. She is widely considered one of the most passionate and respected dental coaches. She is an educator in the field of oral systemic health, as well as founder and CEO of TIPS Medical Billing. Thanks to our episode sponsors: Septodont USA - https://www.septodontusa.com/ GC America - https://www.gc.dental/

This panel was recorded September 18, 2025.⁠⁠⁠⁠ We hope you'll join us live in the future to ask your own questions and participate in the attendee chat! See similar events on demand and read other free MedTech resources at ⁠RQMplus.com⁠.Manufacturers often focus on MDR or IVDR and miss cross-cutting EU laws that impact CE marking, technical documentation, quality systems, and reporting. As a result, devices may be delayed, blocked from the market, or recalled, and manufacturers may suffer legal penalties and reputational harm.In this RQM+ Live! panel discussion, experts from BSI, Brabners, and RQM+ map how sectoral, horizontal, and national requirements fit together, how notified bodies assess them, and how to build an evidence-based path to EU market access.We cover practical implications of recent and emerging regulations, including:Batteries Regulation (EU) 2023/1542AI Act (EU) 2024/1689Packaging and Packaging Waste Regulation (EU) 2025/40European Health Data Space Regulation (EU) 2025/327You'll learn:About the market surveillance regulation (EU) 2019/1020 and EU Blue Guide.How to identify all applicable legislation for your product and verify coverage.What notified bodies expect to see and the typical level of scrutiny.How to structure your compliance register, QMS updates, and regulatory reporting.Transition timelines and planning tactics to avoid last-minute surprises.Who should listen: Regulatory, quality, clinical, legal, and product leaders responsible for EU market access for medical devices and IVDs.Panelists and moderator:Greg Griffin, PhD, MRSE – Technical Specialist, BSIClaire Burrows – Regulatory Partner, BrabnersChris Parr, PMP – Principal, RQM+Jaishankar Kutty, PhD – Vice President of Regulatory Affairs, Reimbursement, & Market Access, RQM+ (Moderator)--

Dr. Jeanette Benigas, SLP, sits down with Oregon SLP Kara Hayden, MS/SLP, to unpack how clinicians organized, lobbied, and helped pass a state law requiring hourly pay, ending pay-per-visit in home health and hospice. They cover timelines, productivity pressure, joining an existing nurses' union, building a small core team, securing a sponsor, writing testimony, and answering the big question: “Won't agencies just pay less?” If you're ready to push for change in your state, pay models, Medicaid rules, or workplace policies, this episode gives you the blueprint and the courage to start.Brought to you by Verse Therapy, the business-in-a-box solution for SLPs who want to start, run, and grow private practice with confidence. Verse Therapy makes private practice a realistic option by providing an AI-integrated EHR, marketing support, cohort trainings, and a team that helps you build your brand and run your practice like a pro. Learn more at versetherapy.com.Stop paying to track ASHA-approved CEUs. Save your money and set up for a FREE CEU/PDH tracker with Speech Therapy PD. While you are there, get $10 off a professional subscription with the code FixSLP10!

In this episode of Medsider Radio, we sat down with Tim Gleeson, CEO of BRIJ Medical, a company rethinking one of the oldest procedures in medicine — surgical wound closure.BRIJ's Brijjit Force Modulating Tissue Bridge is a small, non-invasive clip designed to redistribute tension across incisions, helping wounds heal with fewer complications and smaller scars.An accomplished entrepreneur and investor, Tim also founded and led Novasyte Health through its acquisition by IQVIA and later launched VIDANT Capital. A former Medtronic executive, Tim brings global experience and a lifelong passion for building impactful medtech ventures.In this interview, Tim shares why the biggest opportunities often hide in “boring” markets, how focusing on physician champions and patient psychology drives commercial traction, and why the best fundraisers plan for twice the time and four times the cost.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Tim Gleeson.

Today on The McCarthy Report, Andy and Rich discuss Trump's DOJ reimbursement request, the Bolton indictment, and much more. This podcast was edited and produced by Sarah Colleen Schutte. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Medsider Radio, we sat down with Kate Dilligan, CEO of Cooler Heads.Cooler Heads is a commercial-stage company addressing a problem affecting many chemotherapy patients undergoing treatment for solid tumors: hair loss and the loss of privacy that comes with it. The company's FDA-cleared medical device, Amma, makes scalp cooling accessible by fitting into infusion center workflows rather than disrupting them.Kate brings an unconventional background to medtech — from political fundraising to developing classified software for the U.S. government. As a solo female founder who had never worked in hardware, she started Cooler Heads in 2018 after her own experience with breast cancer. By mid-2025, the company had raised $11 million in Series A funding and placed devices across 27 states, with most accounts having never offered scalp cooling before.In this interview, Kate shares how to design for health system adoption by solving workflow problems first, why saying “no” to scope creep protects your first-generation product, and how political fundraising tactics translate directly to building investor relationships in medtech.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Kate Dilligan.

What happens when politics ignores kids? Pediatrician and South Carolina Senate hopeful Dr. Annie Andrews joins me to talk about why children's health depends on more than just doctor's visits - it depends on the policies shaping their lives. From Medicaid cuts to paid leave, gun safety, and the cost of insulin, Dr. Andrews explains why neutrality in medicine isn't an option and why pediatricians, and parents, have a responsibility to speak up. We discuss: Why Dr. Andrews made the leap from pediatrics to politics How policies like Medicaid cuts directly hurt children, families, and the health care system Why pediatricians and parents need to get louder in advocacy How healthcare has become political and why we need to be louder for our kids' future  The child tax credit and other policies that could transform children's futures How better policy can prevent burnout among doctors and improve care for every family To connect with Dr. Annie Andrews follow her on Instagram @annieandrewsmd, check out all her resources at https://drannieandrews.com/ We'd like to know who is listening! Please fill out our Listener Survey to help us improve the show and learn about you! 00:00 – Why Advocacy Alone Isn't Enough 01:11 – Politics Is Already in Our Lane 02:32 – Meet Dr. Annie Andrews: Pediatrician, Mom, Senate Hopeful 04:04 – From Clinic to Campaign: Why She Ran 07:06 – Kids Left Behind in Red vs. Blue States 09:30 – Why Staying Neutral Can Hurt Kids 12:22 – Advocacy vs. Politics: What Really Creates Change 15:26 – Looking Ahead: Policy Priorities if Elected 16:50 – Medicaid Cuts and What They Mean for Families 22:02 – How Cuts Affect Doctors, Patients, and the Whole System 25:14 – Burnout, Reimbursement, and a Broken System 28:15 – Why Pediatricians Must Step Into Politics 30:17 – Fixing the Workforce Crisis in Pediatrics 33:52 – Final Call to Action: Getting Loud for Kids 35:30 – How to Connect With Dr. Annie Andrews 38:21 – Closing Thoughts: Hope Through Action Our podcasts are also now on YouTube. If you prefer a video podcast with closed captioning, check us out there and ⁠subscribe to PedsDocTalk⁠. Get trusted pediatric advice, relatable parenting insights, and evidence-based tips delivered straight to your inbox—join thousands of parents who rely on the PDT newsletter to stay informed, supported, and confident. ⁠⁠⁠⁠Join the newsletter⁠⁠⁠⁠! And don't forget to follow ⁠⁠⁠⁠@pedsdoctalkpodcast⁠⁠⁠⁠ on Instagram—our new space just for parents looking for real talk and real support. We love the sponsors that make this show possible! You can always find all the special deals and codes for all our current sponsors on the ⁠PedsDocTalk Podcast Sponsorships⁠ page of the website.  Learn more about your ad choices. Visit podcastchoices.com/adchoices